AbbVie Inc. (NYSE:ABBV) has the Market Capitalization of 156.17 Billion. The institutional investor held 161,447 shares of the consumer services company at the end of 2017Q3, valued at $1.38M, up from 113,672 at the end of the previous reported quarter. AbbVie Inc. (NYSE:ABBV) has risen 10.63% since December 29, 2016 and is uptrending. It has underperformed by 6.07% the S&P500.
Wolverine Asset Management Llc increased Abbott Labs (Call) (ABT) stake by 85.71% reported in 2017Q3 SEC filing. Vanguard Group Inc. now owns 115,920,673 shares of the company's stock worth $8,405,409,000 after buying an additional 3,706,941 shares in the last quarter. Altalis Capital Management Llc who had been investing in News Corp New for a number of months, seems to be bullish on the $9.53B market cap company. About 428,450 shares traded. Five9, Inc. (NASDAQ:FIVN) has risen 123.16% since December 29, 2016 and is uptrending. It has underperformed by 22.52% the S&P500. It worsened, as 47 investors sold ABT shares while 563 reduced holdings. Its down 0.15, from 1 in 2017Q2. GLPEY's SI was 20,300 shares in December as released by FINRA. 111 funds opened positions while 421 raised stakes. Shares are clocking price at $98.09 with change of 0.35%. Huntington Natl Bank holds 0% or 2,000 shares. Cincinnati Specialty Underwriters Insur Company stated it has 25,000 shares. Pillar Pacific Management Llc owns 16,818 shares for 0.19% of their portfolio. Ibm Retirement Fund holds 39,571 shares or 0.71% of its portfolio. They expect $1.43 EPS, up 19.17% or $0.23 from last year's $1.2 per share. Keybank Association Oh holds 0.71% or 1.35 million shares. Parkside Fincl Financial Bank, a Missouri-based fund reported 161 shares. (NYSE:ABBV). Wunderlich Managemnt has invested 1.57% of its portfolio in AbbVie Inc. (NYSE:ABBV) on Thursday, December 14. Hamilton Point Ltd Llc invested 1.25% in Accenture plc (NYSE:ACN). Price T Rowe Associate Md accumulated 6.67 million shares. Finally, Palisade Asset Management LLC raised its stake in shares of AbbVie by 17.9% in the 2nd quarter.
Among 24 analysts covering Abbott Laboratories (NYSE:ABT), 15 have Buy rating, 0 Sell and 9 Hold. Therefore 57% are positive. On Monday, October 16 the stock rating was maintained by SunTrust with "Buy". UBS maintained it with "Neutral" rating and $110 target in Wednesday, July 26 report. The rating was maintained by RBC Capital Markets with "Buy" on Monday, July 10. Societe Generale downgraded the shares of ACN in report on Thursday, September 28 to "Hold" rating. The stock presently has a consensus rating of "Buy" and an average price target of $100.26. The company has market cap of $14.73 billion. The stock has "Buy" rating by Leerink Swann on Tuesday, December 5. As per Wednesday, October 11, the company rating was maintained by BMO Capital Markets. The stock has "Market Perform" rating by BMO Capital Markets on Friday, June 10.
Investors sentiment increased to 1.29 in 2017 Q3. Its down 0.01, from 0.88 in 2017Q2. It fall, as 55 investors sold ABBV shares while 640 reduced holdings. Congress Asset Mgmt Co Ma has 89,459 shares for 0.12% of their portfolio. Robeco Institutional Asset Management Bv has 0% invested in Brunswick Corporation (NYSE:BC) for 9,532 shares. Corporate insiders own 0.23% of the company's stock. Moreover, Greenleaf Tru has 0.07% invested in AbbVie Inc. Tortoise Cap Advsrs holds 0% of its portfolio in Core Laboratories N.V. (NYSE:CLB) for 10 shares. Gardner Russo & Gardner Ltd invested in 0.01% or 16,500 shares. Rothschild Il reported 192,733 shares. Menlo Advisors Ltd accumulated 44,898 shares. Blue Chip Partners accumulated 94,836 shares. Mcrae Mgmt Inc has 0.16% invested in AbbVie Inc. (NYSE:ABBV). 162,905 are owned by South Street Advsr Lc. Narrow down focus to firm performance, its weekly performance was 0.17% and monthly performance was 2.80%. William Blair reaffirmed an "outperform" rating and set a $76.00 target price on shares of AbbVie in a research report on Thursday, December 8th. Ten analysts have rated the stock with a hold rating, five have issued a buy rating and two have given a strong buy rating to the company. Therefore 52% are positive. News Corporation had 13 analyst reports since July 27, 2015 according to SRatingsIntel. The firm earned "Equal-Weight" rating on Tuesday, December 1 by Barclays Capital. Deutsche Bank maintained AbbVie Inc. (NYSE:ABBV) on Monday, July 31. While talking about Performance of the Stock, AbbVie Inc. now has a Weekly performance of 0.39%, monthly performance percentage is 2.48 percent, Quarterly performance is 9.93 percent, 6 months performance shows a percent value of 34.92% and Yearly Performance is 57.04 percent. The firm has "Buy" rating given on Monday, June 26 by Jefferies. The stock of Brunswick Corporation (NYSE:BC) has "Buy" rating given on Wednesday, October 18 by KeyBanc Capital Markets. The firm has "Outperform" rating by Oppenheimer given on Friday, March 11. Acropolis Investment Management LLC purchased a new position in shares of AbbVie during the second quarter worth about $106,000. The rating was downgraded by Morgan Stanley on Monday, January 4 to "Equal-Weight".
The current dividend yield for AbbVie Inc.is 2.90%. Jefferies has "Buy" rating and $1700 target.
Analysts await Tilly's, Inc. (NYSE:ABBV) on Thursday, December 14. The business's revenue for the quarter was up 8.8% compared to the same quarter last year. analysts forecast that AbbVie will post 5.55 EPS for the current year. ABBV's profit will be $2.28 billion for 17.09 P/E if the $1.43 EPS becomes a reality. The company reported $1.41 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $1.39 by $0.02.
Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.